GlaxoSmithKline Pharmaceuticals Limited

NSE:GLAXO.NS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

💉 Vaccines

Location

India

Market Cap

USD 5.45 B

Share Price

USD 32.08

Avg Daily Volume

160,595

Change (1 day)

-0.43%

Change (1 year)

-7.02%

Change (YTD)

21.96%

GlaxoSmithKline Pharmaceuticals Limited Accounts Payable for the year ending March 31, 2024: USD 74.98 M

GlaxoSmithKline Pharmaceuticals Limited Accounts Payable is USD 74.98 M for the year ending March 31, 2024, a 44.06% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

GlaxoSmithKline Pharmaceuticals Limited Accounts Payable for the year ending March 31, 2023 was USD 52.05 M, a -31.78% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Accounts Payable for the year ending March 31, 2022 was USD 76.30 M, a 19.85% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Accounts Payable for the year ending March 31, 2021 was USD 63.66 M, a 34.16% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Accounts Payable for the year ending March 31, 2020 was USD 47.45 M, a -18.74% change year over year.